Pharvaris to Participate in H.C. Wainwright 1st Annual Hereditary Angioedema (HAE) Conference
ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing…
ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing…
Live video webcast with moderated roundtable between members of the AIM ImmunoTech Management Team and…
SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today…
Canaca Cannabis Blend 19 Multi Pack Pre-Rolls Tilray Brands’ Canaca Cannabis brings the ‘Wild West’…
SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT)…
PDS0202 neutralized multiple strains of influenza and provided protection against infection in preclinical studies FLORHAM…
Four new members enhance independence and diversity of Board of Directors Alvotech is dual listed…
MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
Four new members enhance independence and diversity of Board of Directors Alvotech (NASDAQ and First…
NEW ORLEANS and LONDON, July 14, 2022 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
Single Ascending Dose Portion of Phase 1 Study Completed BOTHELL, Wash., July 14, 2022 (GLOBE…
New Facility in Austin Will Enable Increased Capacity for Internal Pipeline Assets While Accommodating Growing…
CAMBRIDGE, Mass., July 14, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
– Q2 2022 Consolidated Sales Growth of 8.3% to $19.3 million – Year-to-Date Revenue Growth…
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF JUNE 2022 VANCOUVER, BC, CANADA, July 14,…
CAMBRIDGE, Mass., July 14, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…
BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH),…
Arecor Therapeutics plc(“Arecor” or the “Group”) BUSINESS UPDATE Pipeline for future revenue generating partnered collaborations…
As of the July 5, 2022, data cutoff, early CNM-Au8® treatment resulted in a significant…